RM-1995 Photoimmunotherapy, as Monotherapy or Combined With Pembrolizumab, in Patients With Advanced CuSCC and HNSCC
Cutaneous Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma, Rakuten Medical, RM-1995, RM-1995-101, HNSCC, CUSCC, PIT, photoimmunotherapy, skin cancer, skin, head and neck cancer, Carcinoma, Squamous Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck, Pembrolizumab
Lead Scientist at UCSD
- Charles Coffey, MD
Charley Coffey, MD is a board-certified otolaryngologist and fellowship-trained head and neck cancer surgeon, with expertise in the diagnosis and management of patients presenting with a broad range of benign and malignant tumors of the head and neck.
- accepting new patients at some sites,
but this study is not currently recruiting here
- Start Date
- Completion Date
- Rakuten Medical, Inc.
- Phase 1 research study
- Study Type
- Expecting 36 study participants
- Last Updated